Kezar Life Sciences Inc
(KZR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 62,882 | 57,094 | 26,382 | 22,908 | 21,228 |
| Marketable Securities | 145,473 | 63,665 | 102,593 | 119,400 | 119,219 |
| Other current assets | 729 | 820 | 915 | 961 | 1,631 |
| TOTAL | $211,654 | $124,753 | $133,346 | $145,678 | $144,811 |
| Non-Current Assets | |||||
| PPE Net | 3,283 | 2,980 | 3,017 | 3,204 | 3,435 |
| Other Non-Current Assets | 2,996 | 3,156 | 3,309 | 3,455 | 3,596 |
| TOTAL | $6,279 | $6,136 | $6,326 | $6,659 | $7,031 |
| Total Assets | $217,933 | $130,889 | $139,672 | $152,337 | $151,842 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,028 | 1,543 | 1,633 | 3,578 | 2,358 |
| Accrued Expenses | 4,985 | 5,171 | 3,186 | 2,889 | 3,021 |
| Other current liabilities | N/A | N/A | 7 | 14 | 21 |
| TOTAL | $8,212 | $7,872 | $5,944 | $7,561 | $6,442 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,622 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 3,223 | 3,536 | 3,842 | 4,139 | 4,422 |
| TOTAL | $12,845 | $3,536 | $3,842 | $4,139 | $4,422 |
| Total Liabilities | $21,057 | $11,408 | $9,786 | $11,700 | $10,864 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,671 | 4,915 | 4,819 | 4,809 | 4,807 |
| Common Shares | 56 | 49 | 48 | 48 | 46 |
| Retained earnings | -180,654 | -166,442 | -151,980 | -139,018 | -126,024 |
| Other shareholders' equity | -291 | -195 | -155 | -140 | -137 |
| TOTAL | $196,876 | $119,481 | $129,886 | $140,637 | $140,978 |
| Total Liabilities And Equity | $217,933 | $130,889 | $139,672 | $152,337 | $151,842 |